BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 34238227)

  • 21. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
    Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
    Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
    [No Abstract]   [Full Text] [Related]  

  • 22. Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
    Lima SF; Gogokhia L; Viladomiu M; Chou L; Putzel G; Jin WB; Pires S; Guo CJ; Gerardin Y; Crawford CV; Jacob V; Scherl E; Brown SE; Hambor J; Longman RS
    Gastroenterology; 2022 Jan; 162(1):166-178. PubMed ID: 34606847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Ishikawa D; Sasaki T; Osada T; Kuwahara-Arai K; Haga K; Shibuya T; Hiramatsu K; Watanabe S
    Inflamm Bowel Dis; 2017 Jan; 23(1):116-125. PubMed ID: 27893543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
    Kunde S; Pham A; Bonczyk S; Crumb T; Duba M; Conrad H; Cloney D; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):597-601. PubMed ID: 23542823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.
    Quraishi MNN; Yalchin M; Blackwell C; Segal J; Sharma N; Hawkey P; McCune V; Hart AL; Gaya D; Ives NJ; Magill L; Loi S; Hewitt C; Gerasimidis K; Loman NJ; Hansen R; McMullan C; Mathers J; Quince C; Crees N; Iqbal T
    BMJ Open; 2019 Nov; 9(11):e030659. PubMed ID: 31719078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis.
    Ponce-Alonso M; García-Hoz C; Halperin A; Nuño J; Nicolás P; Martínez-Pérez A; Ocaña J; García-Pérez JC; Guerrero A; López-Sanromán A; Cantón R; Roy G; Del Campo R
    Front Immunol; 2021; 12():683387. PubMed ID: 34149723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis.
    Saleh A; Parsa S; Garza M; Quigley EMM; Abraham BP
    Dig Dis; 2023; 41(4):656-665. PubMed ID: 36858036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis.
    Singh A; Mahajan R; Kahlon BK; Dhaliwal AS; Midha V; Mehta V; Bansal N; Singh D; Sood A
    Indian J Gastroenterol; 2022 Aug; 41(4):389-396. PubMed ID: 36121613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific fungi associated with response to capsulized fecal microbiota transplantation in patients with active ulcerative colitis.
    Chen Q; Fan Y; Zhang B; Yan C; Chen Z; Wang L; Hu Y; Huang Q; Su J; Ren J; Xu H
    Front Cell Infect Microbiol; 2022; 12():1086885. PubMed ID: 36683707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
    Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
    BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrence of moderate to severe ulcerative colitis after fecal microbiota transplantation treatment and the efficacy of re-FMT: a case series.
    Dang XF; Qing-Xi Wang ; Yin Z; Sun L; Yang WH
    BMC Gastroenterol; 2020 Nov; 20(1):401. PubMed ID: 33243141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial.
    Kedia S; Virmani S; K Vuyyuru S; Kumar P; Kante B; Sahu P; Kaushal K; Farooqui M; Singh M; Verma M; Bajaj A; Markandey M; Sachdeva K; Das P; Makharia GK; Ahuja V
    Gut; 2022 Dec; 71(12):2401-2413. PubMed ID: 35973787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
    Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
    Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Fang H; Fu L; Wang J
    Biomed Res Int; 2018; 2018():8941340. PubMed ID: 30302341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal transplantation for ulcerative colitis: current evidence and future applications.
    Lopetuso LR; Ianiro G; Allegretti JR; Bibbò S; Gasbarrini A; Scaldaferri F; Cammarota G
    Expert Opin Biol Ther; 2020 Apr; 20(4):343-351. PubMed ID: 32083498
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study.
    Sood A; Mahajan R; Singh A; Midha V; Mehta V; Narang V; Singh T; Singh Pannu A
    J Crohns Colitis; 2019 Sep; 13(10):1311-1317. PubMed ID: 30873549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal microbiota transplantation in ulcerative colitis.
    Blanchaert C; Strubbe B; Peeters H
    Acta Gastroenterol Belg; 2019; 82(4):519-528. PubMed ID: 31950808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease.
    Goyal A; Yeh A; Bush BR; Firek BA; Siebold LM; Rogers MB; Kufen AD; Morowitz MJ
    Inflamm Bowel Dis; 2018 Jan; 24(2):410-421. PubMed ID: 29361092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study.
    Sokol H; Landman C; Seksik P; Berard L; Montil M; Nion-Larmurier I; Bourrier A; Le Gall G; Lalande V; De Rougemont A; Kirchgesner J; Daguenel A; Cachanado M; Rousseau A; Drouet É; Rosenzwajg M; Hagege H; Dray X; Klatzman D; Marteau P; ; Beaugerie L; Simon T
    Microbiome; 2020 Feb; 8(1):12. PubMed ID: 32014035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.
    Tian Z; Liu J; Liao M; Li W; Zou J; Han X; Kuang M; Shen W; Li H
    Dig Dis Sci; 2016 Aug; 61(8):2262-2271. PubMed ID: 26846120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.